Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUnity Health Toronto

About this trial

The objective of this randomized controlled trial is to evaluate the effectiveness of a low cumulative dose of epinephrine compared to a standard cumulative dose of epinephrine during resuscitation from ventricular fibrillation (VF) or ventricular tachycardia (VT) in adult out-of-hospital cardiac arrest (OHCA) patients.

Eligibility criteria

Qualifiers

Out-of-hospital cardiac arrest treated by paramedics

Initial recorded cardiac rhythm of VF or pulseless VT, or, AED shock on first analysis administered or witnessed by EMS (paramedic or fire)

Established intravenous vascular access

Disqualifiers

Known or apparent age <18 years

Initial recorded cardiac rhythm of VF or pulseless VT, or, AED shock on first analysis administered or confirmed by paramedics

Cardiac arrest due to an obvious non-cardiac primary cause (e.g. blunt or penetrating trauma, exsanguination, burns, drug overdose, drowning, anaphylaxis, sudden asphyxiation, etc.)

Administration of intramuscular, endotracheal tube, or intraosseous epinephrine

Trial design

Treatments tested in this trial

  • Epinephrine

Treatment groups

3,790 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Unity Health Toronto

Lead sponsor

Canadian Institutes of Health Research (CIHR)

Collaborator

Pfizer

Collaborator